Hansa Biopharma Nomination Committee formed
Lund November 19, 2019. Hansa Biopharma today announced that the Nomination Committee has been formed in accordance with the principles adopted by the Annual General Meeting (AGM) on May 22, 2019 and has the following composition: • Erika Kjellberg Eriksson representing Nexttobe AB, • Anna Sundberg representing Handelsbanken Funds• Sven Sandberg representing Thomas Olausson and Gladiator • Ulf Wiinberg, Chairman of the Board The Chairman of the Board shall also summon the first meeting of the Nomination Committee.The function of the Nomination Committee is to